Skip to main content
SpringerLink
Log in

Priligy gets nod from CHMP to expand European marketing

  • News item
  • Published:
Reactions Weekly Aims and scope

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. EMA.Questions and answers on Priligy (dapoxetine, 30 mg and 60 mg tablets) - Outcome of a procedure under Article 29 of Directive 2001/83/EC as amended. Internet Document: [2 pages], 20 Jan 2012. Available from: URL: http://www.ema.europa.eu

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Priligy gets nod from CHMP to expand European marketing. React. Wkly. 1397, 3 (2012). https://doi.org/10.2165/00128415-201213970-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201213970-00007

Keywords

Search

Navigation